Login / Signup

Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study.

Siya KongKeting HuangJun WangXiaoyong WangNingmin YangYu DongYa ZhuangYini DangGuoxin ZhangFeng Ye
Published in: Gut pathogens (2020)
TBQT was more effective than LBQT as a second-line strategy after CBQT failure. In the absence of antibiotic susceptibility testing, AFEB therapy might be used as a rescue therapy to eradicate H. pylori and avoid levofloxacin resistance.Trial registration: Chinese Clinical Trial Registry (www.chictr.org.cn): ChiCTR1900027743.
Keyphrases